Financials

  • Market Capitalization 24.48 B
  • Employee 7 807
  • Founded 2008
  • CEO Uğur Şahin
  • Website www.biontech.de
  • Headquarter Germany
  • FIGI BBG00Q70B3V1
  • Industry Biotechnology

Related tickers

#NamePrice24h %7d %1M %1Y %Market CapLast 7 Days
507
ROIV
Roivant Sciences Ltd. - Common Shares
34.69 USD-7.69%-4.44%+2.36%+89.46%25.06 B USD
513
INCY
Incyte Corporation - Common Stock
124.39 USD-2.62%-2.68%-3.48%+48.35%25.21 B USD
569
UTHR
United Therapeutics Corporation - Common Stock
515.31 USD-2.39%+0.43%-2.05%+67.77%22.10 B USD
680
JAZZ
Jazz Pharmaceuticals plc - Ordinary Shares
244.52 USD-2.62%-3.84%-4.95%+74.66%15.87 B USD

Frequently asked questions about BioNTech SE American Depositary Share

What is the BioNTech SE American Depositary Share stock price today?

The current price of BioNTech SE American Depositary Share (BNTX) is 102.03. Over the past 24 hours, the stock has changed by -8.41%. Follow the BNTX chart for real-time price dynamics.

What is the stock ticker of BioNTech SE American Depositary Share?

BioNTech SE American Depositary Share trades under the ticker BNTX. Tickers can differ by exchange, so always check the exchange and instrument details before trading.

Is BioNTech SE American Depositary Share stock going up?

BNTX has changed by -12.47% over the last week, +10.42% over the last month, and +0.29% over the last year. Review the chart to see whether the current move is part of a broader trend.

What is the market capitalization of BioNTech SE American Depositary Share?

BioNTech SE American Depositary Share currently has a market capitalization of 24.48 B. Market capitalization reflects the total market value of a company's outstanding shares and is commonly used to compare companies by size.

Does BioNTech SE American Depositary Share release financial reports?

Yes. You can track BioNTech SE American Depositary Share financial reports and review yearly or quarterly fundamentals on metatrader.com, including revenue, net income, dividends, and valuation metrics.

How many employees does BioNTech SE American Depositary Share have?

As of the latest available data, BioNTech SE American Depositary Share has 7 807 employees. Workforce size can provide additional context about the company's scale and operations.

How can I buy BioNTech SE American Depositary Share stock?

You can buy BioNTech SE American Depositary Share (BNTX) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.

Should I invest in BioNTech SE American Depositary Share stock?

Investing in BioNTech SE American Depositary Share requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the BNTX chart and related analysis on metatrader.com as part of your research.

BioNTech SE - American Depositary Shares

BioNTech SE is a German multinational biotechnology company headquartered in Mainz that develops immunotherapies and vaccines, particularly for cancer and infectious diseases. The company utilizes technology platforms including mRNA-based therapies, targeted therapies, and immunomodulators, to develop its treatments. BioNTech's pipeline includes several late-stage programs in oncology testing combination therapy approaches to improve treatment outcomes. In the field of infectious diseases, BioNTech, partnering with Pfizer, developed Comirnaty, the first approved mRNA-based vaccine, which was widely used during the COVID-19 pandemic.

News